Regarding the EGFR ligands, we found that EGF was the predominant EGFR ligand in lymphoma, hepatocarcinoma, colon carcinoma, melanoma, breast cancer, myeloma and reticulum cell sarcoma cell lines (Figure 1A). This evidence concerns the gene EGF and colon carcinoma.